Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-21Clinical Trial Update: Clinical Trial Study on the Improved New Method of Acupotomy for AS [NA]
A clinical trial evaluating an improved acupotomy method for ankylosing spondylitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-13Clinical Trial Update: Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis
The trial evaluating enhanced clinics for patients with ankylosing spondylitis and psoriatic arthritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-01-11Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy [Phase 3]
Phase 3 trial evaluating filgotinib in biologic-naïve ankylosing spondylitis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-01-11Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy [Phase 3]
Phase 3 trial evaluating filgotinib in active ankylosing spondylitis was withdrawn.
-
EMA withdrawal · 2020-02-20EMA Lapsed: Lifmior (etanercept) — Pfizer Europe MA EEIG
The European Medicines Agency indicates Lifmior (etanercept) has lapsed; the product is no longer active in the market for its indicated con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2019-03-06EMA Withdrawn: Cyltezo (adalimumab) — Boehringer Ingelheim International GmbH
The EMA withdrew Cyltezo (adalimumab) from Boehringer Ingelheim International GmbH, affecting multiple indications including hidradenitis su…
-
EMA withdrawal · 2019-03-05EMA Withdrawn: Solymbic (adalimumab) — Amgen Europe B.V.
Solymbic (adalimumab) has been withdrawn from the market by Amgen Europe B.V.
-
CLINICAL_TRIALS withdrawal · 2017-03-06Clinical Trial Update: Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα [Phase 3]
A Phase 3 trial evaluating antiviral prophylaxis for HBsAg-positive or HBcAb-positive/HBsAb-negative patients starting anti-TNF therapy has …
-
CLINICAL_TRIALS withdrawal · 2016-10-31Clinical Trial Update: 99m-Technetium- Glucosamine in Arthritis
A clinical trial evaluating 99m-Technetium-Glucosamine for rheumatoid arthritis and ankylosing spondylitis is no longer available, indicatin…
-
CLINICAL_TRIALS withdrawal · 2015-12-02Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
The study evaluating golimumab in Filipino patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis has been with…
-
CLINICAL_TRIALS withdrawal · 2015-04-30Clinical Trial Update: Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451) [Phase 4]
The Phase 4 clinical trial evaluating early treatment with infliximab for hip arthritis associated with ankylosing spondylitis has been with…
-
CLINICAL_TRIALS withdrawal · 2014-10-15Clinical Trial Update: An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs) [Phase 4]
A Phase 4 trial evaluating the efficacy and safety of tramadol/acetaminophen versus diclofenac for pain in adults with ankylosing spondyliti…
-
CLINICAL_TRIALS withdrawal · 2014-09-16Clinical Trial Update: Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) [Phase 3]
The Phase 3 study of ixekizumab in active ankylosing spondylitis has been withdrawn. This trial has been removed from the study portfolio.
-
CLINICAL_TRIALS withdrawal · 2009-01-05Clinical Trial Update: Methotrexate in the Treatment of Axial Spondyloarthritis [Phase 4]
Phase 4 clinical trial evaluating methotrexate for axial spondyloarthritis was withdrawn.
-
EMA withdrawal · 2008-02-14EMA Withdrawn: Trudexa (adalimumab) — Abbott Laboratories Ltd.
EMA has withdrawn Trudexa (adalimumab) from the market.